Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:PFE)

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

Business Wire 8 days ago

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease

Business Wire 10 days ago

ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager

PR Newswire 11 days ago

Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts

Business Wire March 20, 2024

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease

Business Wire March 13, 2024

Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Business Wire March 12, 2024

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire March 5, 2024

Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth

Business Wire February 29, 2024

Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults

Business Wire February 29, 2024
View More News ››

Opinion & Analysis (NYSE:PFE)

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

Stockhouse Editorial July 29, 2020

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Stockhouse Editorial June 18, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

Streetwise Reports July 31, 2019

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Streetwise Reports July 9, 2019

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017
View More Opinion ››

Bullboard Posts (NYSE:PFE)

What is management doing?

I can't understand what is going on? Waiting for the next board meeting to discuss salary at their level? shareholders are not...
ecolo101 - 2 days ago

Resistance seems to be at $24

Not impossible to see lower number until we reach resistance. glta
ecolo101 - 4 days ago

Now the $25

Ouc ouch ouch so frustrating, no mojo to come back up. not too many positive on this one. The bigger they get, they cut themselves...
ecolo101 - 7 days ago

From $60 to $26

And just stalling right there... and cruising in a tight bracket 26-28$ for how long? they have done so much money during the...
ecolo101 - 9 days ago

$33-34 should be

A reasonable bounce back to decent fair value for this beaten stock. But for some reasons that I can not explain there is obscure forces...
ecolo101 - 13 days ago

Ouch

It is no fun watching it going nowhere than down. how come they can spark a little action from the management leadership. even Cramer...
ecolo101 - April 4, 2024
View more Bullboard ››

Imagine Lithium Inc.

Imagine Lithium Inc.

Imagine Lithium is an exploration company advancing its Jackpot Lithium Project in Nipigon, Ontario. The project has a ...
View More »